课题基金 / 基金详情

The comparison of virus genome and immune reaction between asymptomatic carriers and chronic hepatitis patients infected with HBV.

The comparison of virus genome and immune reaction between asymptomatic carriers and chronic hepatitis patients infected with HBV.
无症状携带者与乙型肝炎病毒感染者的病毒基因组及免疫反应比较
批准号:
13670495
负责人:
MARUYAMA Toshiyuki
金额:
$0.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

MARUYAMA Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antigen presenting cells were induced from spleen cells of HBcAg transgenic mouse (Tg10c), or HBeAg transgenic mouse (Tg30e), and HBcAg transgenic mouse has the better ability to induce HBcAg specific antigen presenting activity, but lower ability to express HBeAg.Antibody production against HBcAg or or HbeAg was slightly low in Tg10c, and almost lost in Tg30e.20 asymptomatic HBV carrier patients (group A) who has no symptom and no elevation of liver function test and 25 HBV related chronic hepatitis patients (group B) were analyzed for virolo9ical profile and cYtokine production.Although few mutations were detected in group A patients, several mutations were found in group B patients. Lots of mutations were concentrated in the core region. However, chronic hepatitis B does not appear to be caused by a specific genomic mutation or an amino acid mutation.In the cytokine production assay, the average interleukin 2 levels were higher in group B patients than that in group A patients. Similarly, and IFNγ levels were higher in group B patients than that in group A patients.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hirayama M., Maruyama T.: "IgG1 anti-P2 as a marker of response to interferon in patients with chronic hepatitis C."Clinical Experimental Immunology.. 126. 92-100 (2001)
Hirayama M.、Maruyama T.:“IgG1 抗 P2 作为慢性丙型肝炎患者干扰素反应的标志物。”临床实验免疫学.. 126. 92-100 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Moriya K.: "Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis."Cancer Research. 61. 4365-4370 (2001)
Moriya K.:“丙型肝炎病毒相关肝癌发生的小鼠模型中无炎症情况下的氧化应激。”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Using microbubbles to increase the destruction of liver tumors by high-intensity focused ultrasound
    • 批准号:
      15390228
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.13万
    • 财政年份:
      2003
    • 负责人:
      MARUYAMA Toshiyuki
    • 依托单位:
    The mechanism which causes fulminant hepatic failure after immune suppression therapy on HBV carrier patients
    • 批准号:
      11670480
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1999
    • 负责人:
      MARUYAMA Toshiyuki
    • 依托单位:
    Investigation for the development of vaccine against hepatitis C virus
    • 批准号:
      09670515
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1997
    • 负责人:
      MARUYAMA Toshiyuki
    • 依托单位:
    国内基金
    海外基金
    背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
    • 批准号:
      82371224
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      马柯
    • 依托单位:
    CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
    • 批准号:
      82371791
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      刘永波
    • 依托单位:
    Consequences of MALT1 mutation for B cell tolerance
    • 批准号:
      32100719
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      James Qun Wang
    • 依托单位:
    肠上皮内γδT细胞诱导抗原特异性Treg的体内机制及其对肾移植慢性排斥的抑制作用研究